Clinical Study
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
Table 2
Overall toxicity during all treatment courses by type and grade.
| Toxicity | Grades 1-2 | Grades 3-4 |
| Haematological toxicity | | | Thrombocytopenia | 11 (46%) | 5 (21%) | Neutropenia | 4 (17%) | 3 (12%) | Anemia | 1 (4%) | 0 | Nonhaematological toxicity | | | Nausea/vomiting | 2 (8%) | 0 | hypertransaminasemia | 5 (21%) | 0 | Asthenia | 2 (8%) | 0 |
|
|